“They’ve been particularly limited for treatments that can be given acutely to patients when they first experience an attack of PSVT. The program includes reimbursement support and copay assistance for the majority of patients with commercial insurance covering Cardamyst. A total of 1107 patients took ≥1 etripamil test dose while in sinus rhythm, and no significant changes in average baseline heart rate or blood pressure was observed within 45 minutes of administration. “And the efficacy data demonstrate that it’s fast, effective, and lasts for well beyond 30 minutes. We keyed in on 30 minutes because that was our primary endpoint, and that’s often the time in which patients have to make a decision.